# Effects of Microplegia on Transfusion Rates After Cardiac Surgery

Study · id `cardio:ct-nct05076604` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05076604](<https://clinicaltrials.gov/study/NCT05076604>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05076604

Browse, organ or system: Heart  
Browse, condition area: Valve and congenital heart disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 314 participants.

## Technical summary

Registry record NCT05076604. Randomized; double masking; primary purpose supportive care. Start 2019-03-25 (actual); primary completion 2023-06-01 (actual). Results posted on 2024-08-06.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose supportive care
- Phase: Phase 4
- Enrolled: 314 participants (enrolled count; ClinicalTrials.gov record NCT05076604, source copy `cardio:ctgov-nct05076604-2024-08-06`, retrieved 2026-10-26)
- Started: 2019-03-25 (actual) (ClinicalTrials.gov record NCT05076604, source copy `cardio:ctgov-nct05076604-2024-08-06`, retrieved 2026-10-26)
- Primary completion: 2023-06-01 (actual) (ClinicalTrials.gov record NCT05076604, source copy `cardio:ctgov-nct05076604-2024-08-06`, retrieved 2026-10-26)
- Completion: 2023-08-01 (actual) (ClinicalTrials.gov record NCT05076604, source copy `cardio:ctgov-nct05076604-2024-08-06`, retrieved 2026-10-26)
- Results first posted: 2024-08-06 (ClinicalTrials.gov record NCT05076604, source copy `cardio:ctgov-nct05076604-2024-08-06`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT05076604, source copy `cardio:ctgov-nct05076604-2024-08-06`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05076604-2024-08-06`, retrieved 2026-10-26)

## The registry's words

- Brief title: Effects of Microplegia on Transfusion Rates After Cardiac Surgery
- Condition: Aortic Valve Disease
- Condition: Mitral Valve Disease
- Intervention (Drug): Cardioplegia Solution
- Intervention (Drug): Microplegic Solution No. 1
- Lead sponsor: Washington University School of Medicine
- Lead sponsor class: OTHER
- Collaborator: Quest Medical, Inc
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Heart valve disease (`cardio:heart-valve-disease`)
- Registry lists this organization as the lead sponsor: Washington University School of Medicine (`cardio:org-washington-university-school-of-medicine`)

## Provenance

Content hash: 4c6775ea40d3580084bfe3cb7e6d42368d02ca561f63f45c28341bcb106d3e89
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
